Schwazze Announces Transition to OTC Expert Market Following Form 10-Q Filing Delay

Medicine Man Technologies, Inc., widely recognized as Schwazze, has made a significant announcement concerning its stock trading venue. With its ticker symbol SHWZ, the Denver-based cannabis company revealed that it will be moving to the OTC Expert Market. This update comes as a direct result of the firm's delayed submission of its Form 10-Q, a crucial financial report detailing the company's quarterly performance. This report was required for the period ended and the delay has necessitated this transition.

Implications of the Transition for Investors

The transition of Schwazze's common stock to the OTC Expert Market may have implications for current and prospective investors. While SHWZ has been available to investors through more regulated trading platforms, the shift to the OTC Expert Market denotes a trading platform designed for professional and institutional investors, focusing primarily on companies that are not required to adhere to the same level of financial reporting standards as those listed on major exchanges.

What the Delayed Filing Means for Schwazze

The delay in filing the Form 10-Q highlights the challenges Schwazze faces with respect to financial reporting compliance. For investors, it is a reminder of the importance of timely and transparent disclosure, which is crucial in assessing a company's health and making informed investment decisions. The company's management is handling the issue and is expected to provide updates on the status of the filing and associated timelines.

Schwazze, Transition, OTC